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Abstract
The physiopathology of obstructive sleep apnea-hypopnea syndrome is multifactorial. Gender and obesity status, as well as genetic, anatomic, 
and hormonal factors, together with respiratory drive, interact in a diverse manner in the physiopathology and clinical expression of the 
disease. Obesity is the main risk factor, since increases in body mass index, visceral fat, and neck circumference are strong predictors of 
the disease. Progesterone increases the activity of the upper airway dilator muscles and therefore plays a protective role in premenopausal 
women. This explains the fact that the prevalence of the disease is higher in postmenopausal patients with polycystic ovary syndrome, as well 
as in males. Evidence supports the fact that, as individuals grow older, there is a decrease in muscle tonus, with a consequent reduction in 
the dimensions of the upper airway lumen. Craniofacial anomalies, such as in retrognathia or micrognathia, are accompanied by posterior 
positioning of the tongue and can result in narrowing of the upper airway lumen. Finally, decreased respiratory drive has been detected in 
patients with obstructive sleep apnea-hypopnea syndrome and hypercapnia.
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Introduction
This review aims to analyze the principal arti-
cles in the literature regarding the pathophysiology 
of obstructive sleep apnea-hypopnea syndrome 
(OSAHS). We address the concept of the disease and 
the influence of sleep on respiration, as well as the 
interaction of anatomical, functional, genetic and 
neural factors in its genesis (Chart 1). 
Concept
Individuals with OSAHS present recurrent 
episodes of partial or complete upper airway obstruc-
tion during sleep. Despite inspiratory effort, airflow 
is decreased (hypopnea) or completely interrupted 
(apnea). The lack of adequate alveolar ventilation 
generally results in oxyhemoglobin desaturation 
and, in cases of prolonged events, in a progressive 
increase of arterial carbon dioxide tension (PaCO2). 
These respiratory events are normally interrupted 
by micro-arousals. According to the American 
Academy of Sleep Medicine criteria,(1) OSAHS 
should be suspected in patients presenting excessive 
daytime sleepiness unattributable to other factors, 
as well as in those presenting at least two of the 
following symptoms, likewise unexplained by other 
factors: choking during sleep, recurrent arousals, 
nonrestorative sleep, daytime fatigue/difficulty in 
concentration and five or more obstructive respira-
tory events per hour of sleep, as determined through 
all-night polysomnography. These events can be, 
variously, episodes of apnea, hypopnea or respira-
tory effort related to awakening. 
Anatomy
The upper airways are divided into four anatom-
ical subsegments: the nasopharynx, located between 
the nostrils and hard palate; the retropalatal pharynx, 
Chart 1 – Mechanisms involved in the genesis of obstructive sleep apnea-hypopnea syndrome.
Age
It is believed that with aging the activity of the upper airway musculature is decreased. 
Gender
Prevalence is higher in men than in women. Women present greater genioglossus muscle tone, which can be 
considered a defense mechanism designed to maintain upper airway permeability. 
Hormones
Estrogen and progesterone promote the maintenance of upper airway permeability (by improving muscle 
tone), as well as increasing respiratory drive. The androgens induce greater fat deposition and relaxation of 
the pharyngeal dilator muscles. Polycystic ovary syndrome is characterized by a higher level of circulating 
androgens and, therefore, a higher risk of sleep apnea. Menopause also increases the chances of sleep 
apnea.
Anatomical factors
Micrognathia and hypoplasia of the mandible are associated with the posterior positioning of the base of the 
tongue and with upper airway narrowing. Thickening of the lateral pharyngeal walls also cause upper airway 
narrowing.
Genetic factors
Some risk factors, such as craniofacial structure, distribution of body fat, neural control of the upper airways 
and central respiratory command, can be inherited. 
Posture and gravity
The dorsal decubitus position promotes the posterior positioning of the tongue and soft palate, thereby 
reducing the area of the oropharynx. 
Body fat
High body mass index. Central or visceral obesity is quite important. Predisposing factors: abdominal circum-
ference > 94 cm in men and > 80 cm in women; neck circumference > 40 cm. 
Other causes
Acromegaly, Down’s syndrome, hypothyroidism, genetic syndromes and deposition diseases (amyloidosis and 
mucopolysaccharidosis) can promote the narrowing of the upper airways, which is a predisposing factor for 
sleep apnea.
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located between the hard palate and soft palate; the 
oropharynx, which extends from the soft palate to 
the epiglottis; and the hypopharynx, which extends 
from the base of the tongue to the larynx. 
The last three subsegments compose the collaps-
ible portion of the pharynx. The absence of bone 
and cartilage in these segments enables their lumen 
to remain permeable due to the action of muscles, 
which actively constrain and dilate the lumen of the 
upper airways.(2) Soft tissue structures, including 
the tonsils, soft palate, uvula, tongue and lateral 
wall of the pharynx, form the walls of the upper 
airways. The principal craniofacial bone structures 
that determine the dimensions of the upper airways 
are the mandible and hyoid bone. It is believed that 
the muscles and soft tissues are supported by these 
structures.(2) 
Measurements of the tranverse area of the 
various upper airway segments can be taken in 
different ways: acoustic reflection; conventional or 
high resolution tomography; or magnetic resonance 
imaging. Studies using these various techniques 
have obtained a great diversity of values. That 
simple difference in the findings might be justified 
by individual variability, but also by the different 
locales of measurement.(2) There is a consensus that 
the smallest upper airway diameter during wakeful-
ness is found in the retropalatal oropharynx, which 
makes this point a potential locale for its collapse 
during sleep.(2) However, it is known that obstruction 
can occur, either simultaneously or sequentially, in 
any of the four subsegments. 
Respiration and Sleep
Pulmonary ventilation is controlled by two 
systems: an automatic one located in the brainstem; 
and a voluntary one in the cerebral cortex. The 
central chemoreceptors are sensitive to variations in 
pH; the increase of carbonic gas reduces pH, thereby 
stimulating those receptors. The peripheral chemore-
ceptors are sensitive to a decrease in arterial oxygen 
tension and in pH. Those chemoreceptors stimulate 
the respiratory centers located in the brainstem and 
control ventilation in an automatic or metabolic 
manner. Voluntary control is capable of dominating 
the function of the brainstem, within certain limits. 
For example, we can reduce PaCO2 through volun-
tary hyperventilation. However, hypoventilation is 
more difficult, since the interruption of ventilation 
is limited by metabolic factors.(3)
The increase in PaCO2 stimulates the respiratory 
center and increases ventilation. Active hyper-
capnia activates the upper airway dilator muscles 
and decreases their collapsibility by increasing the 
tension of the upper airway walls.(4)
During sleep, the only respiratory control system 
that is active is the automatic one. Therefore, respi-
ration during sleep depends on metabolic factors as 
well as on the activation of central and peripheral 
chemoreceptors. Sleep reduces the sensitivity of the 
chemoreceptors, de-activates bulbar neurons and 
decreases overall motor activity, i.e. there is relaxa-
tion of the muscles, including those of the upper 
airways. Those phenomena are well tolerated by 
normal people, although they can lead to respira-
tory disorders in some individuals.
Some OSAHS patients present chronic hypox-
emia, which can affect the synthesis and activity 
of various neurotransmitters, thereby altering the 
function of central and peripheral chemioreceptors 
responsible for ventilatory control. It is believed that 
the alterations resulting from sleep disorders perpet-
uate themselves during wakefulness.(5,6) Patients with 
OSAHS and hypercapnia present a lower ventilatory 
response to hypercapnia, even during wakeful-
ness. However, when treated with nasal continuous 
positive airway pressure, such patients present 
an increase in the diurnal ventilatory response to 
hypercapnia and to hypoxemia, which improves 
diurnal gas exchange.(6) However, respiratory drive 
is within nomal parameters in patients with OSAHS 
and normocapnia.
The alterations that occur in ventilation during 
sleep depend on the phases of sleep.(7) In stages 
3 and 4, ventilation is extremely regular with no 
alteration of the flow volume and respiratory 
frequency. In a normal individual, there are no apnea 
episodes in slow-wave sleep. In rapid eye movement 
(REM) sleep, ventilation becomes irregular with vari-
able flow volume and respiratory frequency, there is 
a loss of upper airway muscle tonus in relation to 
non-REM (NREM) sleep and, at certain moments, 
the arousal threshold can be high. Therefore, REM 
sleep is the moment of greatest risk for patients 
presenting severe, prolonged episodes of sleep 
apnea.(2,7) Episodes of apnea and hypopnea occur 
at maximum frequency during REM sleep, stage 1 
NREM sleep and stage 2 NREM sleep.(7) Occasionally, 
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apnea is more frequent in NREM sleep than in REM 
sleep. However, even in such patients, those events 
that occur in REM sleep are more severe and are 
longer in duration.(2) 
In calm respiration, the lungs are actively 
inflated through the contraction of the diaphragm, 
the external intercostal muscles and the accessory 
muscles involved in inspiration. In that process, 
other muscles play a small role. Such muscles include 
the muscles of the nasal alae, which promote the 
opening of the nostrils, and the small muscles of 
the neck and head, i.e. the upper airway muscles 
(larynx and pharynx).(3,7) The coordinated activation 
of those muscles maintains the permeability of the 
segments of the airways that are prone to occlu-
sion. A wave of activation begins at the muscles of 
the nasal alae and moves caudally, preceding inspi-
ration. If the activity of the upper airway muscles 
are uncoordinated or reduced, the negative pres-
sure generated by the contraction of the diaphragm 
can exceed the support pressure of the pharyngeal 
abductor muscles and cause occlusion or subocclu-
sion of the pharynx.(7) 
In variable extrathoracic obstruction of the 
upper airways, there is a tendency toward collapse 
during inspiration, whereas they remain open during 
expiration.(8)
Therefore, considering the upper airway architec-
ture as an extrathoracic structure, the most critical 
moment of the respiratory cycle for collapse would 
be inspiration. However, among OSAHS patients, 
there is an accentuated reduction in upper airway 
diameter at the end of expiration, so that period 
should also be considered critical.(9)
Negative intrathoracic pressure is transmitted 
to the upper airways during inspiration, thereby 
promoting a reduction in the transverse area of the 
pharynx.(2) The permeability of the upper airways is 
maintained through the balance between intratho-
racic pressure and the abduction force of the 
pharyngeal muscles.(2) During wakefulness in normal 
individuals, the dimensions of the upper airways 
remain practically constant throughout inspiration, 
being smallest at the end of expiration. Inspiration 
is the period of ventilation in which the pharyngeal 
dilator muscles are most active to maintain pharyn-
geal permeability. It is believed that the upper airways 
are more complacent and collapse more easily in 
OSAHS patients, which is why the dilator muscles 
are more active during wakefulness and why there 
is a decrease in activity during sleep.(9) In normal 
individuals, high negative intrathoracic pressure is 
necessary for the upper airways to collapse, whereas, 
in OSAHS patients, such collapse occurs at slightly 
negative pressures or even positive pressures.(2,9)
Pathophysiology
Age
The effect of age on OSAHS prevalence in the 
general population merits greater clarification. 
Studies involving men and women between 20 and 
100 years of age have been carried out in order to 
identify age-specific prevalences. Among women, 
those over 65 years presented the highest preva-
lence of OSAHS, whereas the highest prevalence in 
men was seen among those in the 45 to 64 age 
bracket.(10,11) When the sample was stratified by 
decade of age, was assessed by classifying the sample 
by decade, a peak in the prevalence was observed in 
women from 60 to 69 years of age and in men from 
50 and 59 years of age.(10,11) With respect to severity, 
one study shows that OSAHS is less severe in the 
elderly than in the young, which suggests that the 
diagnostic criteria should be adjusted for age.(11)
It is known that aging correlates positively with 
obesity and neck circumference, i.e., body weight 
and neck circumference increase with age; it is also 
known that obesity and increased neck circumfer-
ence are risk factors for sleep apnea.(12) The data 
regarding age-related changes in the activity of the 
pharyngeal dilator muscles are controversial. Some 
studies show similarities between the young and 
elderly during sleep and wakefulness, whereas more 
recent studies have demonstrated decreased activity 
of these muscles in the elderly.(2) Some authors 
showed that upper airway diameter decreases with 
aging both in men and women.(12)
In women, aging also leads to another very 
important risk factor, menopause.(10) 
Gender
The prevalence of sleep apnea is greater in men 
than in women. Using clinical criteria and polysom-
nography, the prevalence was found to be 1.2% in 
women and 3.9% in men.(10) Estimates show that 
the male/female ratio varies from 2:1 to 4:1.(10) 
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The prevalence of sleep apnea is higher in 
menopausal women than in premenopausal women. 
However, the prevalence is still significantly lower 
in menopausal women than in men when adjusted 
for age and body mass index (BMI). Hormone 
replacement therapy for postmenopausal women 
seems to be associated with a lower prevalence 
of sleep apnea and makes the prevalence of sleep 
apnea in postmenopausal women equal to that 
seen in premenopausal women.(10) Some authors 
showed that, among women presenting OSAHS, 
100% of premenopausal women were obese (BMI 
> 32.3 kg/m2), as were 100% of postmenopausal 
women undergoing hormone replacement therapy. 
However, the prevalence of obesity in postmeno-
pausal women not undergoing hormone replacement 
therapy is similar to that observed in men of the 
same age (49.4% vs. 42.1%).(10) This confirms, once 
again, that age, obesity and menopause are risk 
factors for sleep apnea. 
Another difference between the genders is related 
to genioglossus muscle tone, which is believed to be 
greater in women, suggesting a defense mechanism 
for the maintenance of upper airway permeability. 
Therefore, in the dorsal decubitus position, men 
present a greater reduction in the dimensions of 
the upper airway lumen than do women. Another 
situation corroborating this hypothesis is that, when 
there is an increase in neck circumference due to fat 
accumulation, the transverse diameter of the upper 
airways remains greater in women than in men, 
suggesting once again that women present a better 
defense mechanism.(12)
Posture and gravity
The shape and dimensions of the upper airways 
depend on the position of the soft tissue structures 
(palate, uvula, tongue and pharyngeal wall), which 
can be influenced by gravity. In the dorsal decu-
bitus position, the tongue and soft palate project 
themselves posteriorly, thereby reducing the area 
of the oropharynx.(2) Some authors conducted an 
anthropometric study of the upper airways using 
the acoustic reflection technique. The evaluation 
was made during wakefulness and involved individ-
uals of different genders, sitting and in the dorsal 
decubitus position. There was no statistical differ-
ence between the genders regarding upper airway 
area and volume in the dorsal decubitus position. 
However, men presented more significant changes 
in the dorsal decubitus position than did women. 
In the sitting position, men presented a greater 
maximum pharyngeal area, larger oropharyngeal 
junction and a larger transversal section of the 
oropharyngeal junction at the glottis.(12)
Anatomical factors
Alterations in the external anatomy of the head 
and neck can be risk factors for developing OSAHS, 
irrespective of obesity. Craniofacial anamolies can 
involve a delay in the development of the mandible, 
which produces mandibular retroposition. This 
micrognathia or mandibular hypoplasia is associ-
ated with the posterior positioning of the base of 
the tongue, which narrows the upper airways.(9,13) 
The presence of an ogival palate in individuals 
with OSAHS is also common because the posterior 
position of the tongue can force the lateral pala-
tine processes to expand over the tongue, wrongly 
positioned, before the fusion of the middle line.(13) 
In the Kushida morphometric model, in addition to 
the height of the palate, the ‘overjet’ (the horizontal 
anteroposterior distance from the upper incisors to 
the lower incisors) is taken into consideration, as 
is the distance between the second maxillary and 
mandibular molars (in millimeters). Those meas-
urements can indicate a small oral cavity, which 
can result in narrowing of the upper airway and 
predispose the individual to OSAHS. These altera-
tions occur independently of patient weight, which 
explains the presence of OSAHS in slim individuals.
In normal individuals, the upper airways present 
a lateral diameter larger than the anteroposterior 
diameter. In OSAHS patients, the inverse occurs: 
the lateral diameter becomes smaller than the 
anteroposterior diameter, which corresponds to a 
narrowing at a critical point, i.e., the retropalatal 
airway. The structures that can cause that effect are 
the lateral pharyngeal walls and the lateral pharyn-
geal fat pad.(2,14) The lateral pharyngeal walls are 
thicker in OSAHS patients. This finding led some 
authors to conclude that the thickening of the 
lateral pharyngeal walls rather than the size of the 
tongue, tonsils or soft palate is the principal causa-
tive anatomical factor of upper airway narrowing in 
OSAHS patients. However, the explanation for the 
narrowing of the lateral walls is unknown. There is 
speculation that the muscle mass of the lateral walls 
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increases due to the weight gain or ‘respiratory 
exercise’ that occurs in sleep apnea, or even due to 
a fold in the pharyngeal wall (which can be reversed 
by using continuous positive airway pressure).
Body fat
Obsesity is an important pathogenic factor 
in sleep apnea.(1,2,9,12,15,16) Approximately 70% of 
OSAHS patients are obese, and obesity is the only 
significant risk factor that is reversible.(16) Obesity is 
evaluated by measuring BMI and classifying individ-
uals based on the degree of obesity, beginning with 
type 1 obesity (BMI > 25 kg/m2).(17) Some authors 
have stated that a BMI of > 30 kg/m2 is a risk factor 
for obstructive sleep apnea.(16)
Other studies have shown that central obesity, 
reflected by the waist/hip ratio, is a similar or even 
better predictor for sleep apnea than is BMI, and 
that the correlation between abdominal and neck 
circumference is a very significant factor, which 
lends credence to the idea that apnea is directly 
related to central obesity.(15) The body circumfer-
ence indices identify individuals presenting central 
obesity patterns that increase the risk of having 
problems related to obesity, regardless of BMI.(18) 
Central or visceral obesity has been more frequently 
associated with apnea than have other forms of 
obesity. Some authors analyzed the distribution of 
body fat using magnetic resonance imaging of the 
neck and abdomen in patients under clinical suspi-
cion of having sleep apnea.(19) The results showed 
a significant correlation between sleep apnea and 
the quantity of intra-abdominal fat, as well as a 
borderline correlation between sleep apnea and 
subcutaneous abdominal fat and no correlation 
between sleep apnea and parapharyngeal or subcu-
taneous fat in the neck region.(19) 
Abdominal circumference is measured at the 
height of the umbilicus, while standing, at the end 
of expiration. Abdominal obesity, a risk marker, is 
defined as an abdominal circumference > 94 cm in 
men or > 80 cm in women. An abdominal circum-
ference > 102 cm in men or > 88 cm in women 
indicates a high risk of arterial hypertension, 
dyslipidemia, diabetes mellitus and cardiovascular 
disease.(20)
Neck circumference is a predisposing factor 
for OSAHS.(9) In one study, the cut-off point was 
estimated at 40 cm, and other authors later identi-
fied the ideal locale of measurement as being the 
cricothyroid membrane.(12,15) It is assumed that the 
increased deposition of fat or soft tissue in the 
region of the neck or adjacent to the upper airways is 
responsible for sleep apnea in obese individuals.(15,19) 
A large neck circumference probably reflects greater 
deposition of fat and soft tissue, which is more 
significantly associated with sleep apnea.(19) Among 
other conditions, acromegaly, Down’s syndrome, 
hypothyroidism, genetic syndromes and deposi-
tion diseases (such as mucopolysaccharidosis and 
amyloidosis) can promote upper airway narrowing, 
which is a predisposing factor for sleep apnea. 
Leptin is an antiobesity hormone that is predom-
inantly produced by the white fatty tissue.(18) High 
leptin levels are correlated with adiposity indices, 
including BMI and percentage of body fat.(15) Leptin 
bonds with specific receptors in the hypothalamus 
and changes the expression of neuropeptides 
that regulate neuroendocrine functions such as 
caloric intake and energy expenditure.(18) A large 
percentage of obese people have high levels of 
circulatory leptin, which indicates that obesity is 
a state of resistance to leptin in many situations. 
It is possible that defects in receptors and nonre-
ceptors are responsible for leptin resistance in 
the obese.(16,18,19) Studies suggest that obesity and 
obstructive apnea are both related to the afore-
mentioned resistance. 
Female and male hormones
There is some evidence that hormonal status 
might influence the dilatory activity of upper airway 
muscles. In premenopausal women, the musculature 
of the genioglossum is highly active in comparison 
to that seen in postmenopausal women and in men 
of the same age. It is therefore believed that, prior 
to menopause, progesterone might be protective 
against sleep apnea.(18) The highest progesterone 
levels are seen in the luteal phase of the menstrual 
cycle. In that period, women experience an increase 
in respiratory drive, which shows one of the func-
tions of that hormone. Exogenous progesterone has 
been associated with a slight but definitive improve-
ment in ventilation during sleep in men and women 
with sleep apnea. Another important hormone is 
estrogen, and its administration is associated with 
a decrease in plasma levels of interleukin 6, which 
are higher in patients with sleep apnea.(10) Therefore, 
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the prevalence of OSAHS is lower in postmenopausal 
women undergoing hormone replacement therapy 
(receiving progesterone and estrogen), since they 
have two protective mechanisms.
In contrast, the exogenous administration of 
testosterone in women and healthy men has been 
associated with greater upper airway collapsibility, 
thereby inducing sleep apnea without causing 
weight gain.(10,21,22) It is believed that high levels 
of androgens might alter the composition of body 
fat and lead to a greater deposit of soft tissue in 
the pharynx, which can also result in relaxation of 
the pharyngeal dilator muscles.(21) Apnea is resolved 
after the exogenous withdrawal of the hormone or, 
in cases of tumors that produce testosterone, after 
tumor resection.(10)
Testosterone plays another important role at 
the central level, in the central chemoreceptors that 
control ventilation.(22) When an individual hyperven-
tilates voluntarily or is in a high altitude situation 
(attempting to capture more oxygen in rarefied air), 
the level of PaCO2 lowers, and the central chem-
oreceptors understand that ventilation is no longer 
necessary, resulting in central apnea. The lowest level 
of PaCO2 capable of causing central apnea varies 
individually. However, we know that the threshold 
for hypocapnic apnea is lower in women than in 
men, i.e. women tolerate a much lower PaCO2 level 
than do men. Although the exact role testosterone 
plays in the central chemoreceptors is unknown, one 
hypothesis is that it increases the sensitivity of the 
chemoreceptors to minimal variations in PaCO2.
(22)
Some authors conducted a study involving eight 
premenopausal women receiving testosterone. They 
showed an increase in the hypocapnic threshold 
and a facilitation of the development of central 
apnea when ventilatory alterations were caused 
during NREM sleep. The mechanism of action of 
testosterone was related to the increase in sensi-
tivity of the central chemoreceptors, since there was 
insufficient time for the development of anatomical 
alterations in the upper airways.(22)
Polycystic ovary syndrome (POS) is an endocrine 
disorder that is more common in premenopausal 
women. Some authors compared eighteen young 
obese POS patients with eighteen healthy young 
women, paired by weight and age, and concluded 
that those in the first group had a significantly 
higher chance of developing sleep apnea than did 
those in the control group.(21) 
Another study, involving 53 women with POS 
and a control group, showed a much higher preva-
lence of sleep apnea in the group of POS patients, 
at a ratio of 30:1. The authors of that study also 
concluded that even nonobese premenopausal 
women with POS presented a higher prevalence 
of sleep apnea.(23) The use of oral contraceptives 
seems to protect women with POS from developing 
OSAHS.(23) There are studies showing that women 
with OSAHS have a higher level of circulating 
androgen hormones than do normal women paired 
by age and weight.(21)
Therefore, women diagnosed with POS should 
be carefully investigated for signs and symptoms 
related to sleep-disordered breathing. We can 
conclude that, in relation to sleep apnea, female 
hormones are protective and male hormones are 
harmful.
Genetic factors
Familial aggregation for OSAHS has been shown 
in studies involving families with various affected 
members. Genetic factors related to craniofacial 
structure, distribution of body fat, neural control 
of the upper airways and the central respira-
tory drive interact to produce the phenotype of 
the syndrome.(24) Therefore, members of the same 
family that share those genetic characteristics might 
present OSAHS. The prevalence of OSAHS in first-
degree relatives of OSAHS probands varies from 
22 to 84% in the various studies. Therefore, the 
importance of investigating family history in the 
evaluation of patients is quite evident.(25)
The literature suggests that ethnic factors must 
be considered in the investigation of individuals with 
OSAHS, since there are cephalometric differences 
that can influence the pathogenesis of the disease. 
One recent study suggests that the anthropometric 
measurement of the head is an important crite-
rion for evaluating the susceptibility to OSAHS.(26) 
Specific genes responsible for the development of 
OSAHS have yet to be identified. 
Conclusion
The prevalence of OSAHS is high, and the clinical 
expression of the disease is variable. Anatomical, 
functional, neural and genetic factors interact in its 
genesis (Chart 1).
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